AG001QMG

159351-69-6 | Rapamycin, 42-O-(2-hydroxyethyl)-

Chemical structure of Rapamycin, 42-O-(2-hydroxyethyl)-, CAS 159351-69-6
AG001QMG
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 159351-69-6
Catalog Number AG001QMG(AGN-PC-0Q7NUC)
Chemical Name Rapamycin, 42-O-(2-hydroxyethyl)-
IUPAC Name (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
InChI InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
InChI Key HKVAMNSJSFKALM-GKUWKFKPSA-N
MDL Number MFCD00929329
Molecular Formula C53H83NO14
Molecular Weight 958.2244
SMILES O=C(N1CCCC[C@H]1C(O[C@H]([C@@H](C[C@H]2C[C@H]([C@@H](CC2)OCCO)OC)C)CC([C@@H](/C=C([C@H]([C@H]3OC)O)C)C)=O)=O)C([C@@]4(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@H](C3=O)C)C)OC)O4)C)=O
UNII 9HW64Q8G6G
Synonyms
001, RAD, 40-O-(2-hydroxyethyl)-rapamycin, Afinitor, Certican, everolimus, RAD 001, RAD, SDZ, RAD001, SDZ RAD, SDZ-RAD, Everolimus, Afinitor, Certican, Zortress, RAD001, SDZ-RAD, 42-O-(2-Hydroxyethyl)rapamycin, 159351-69-6, 40-O-(2-hydroxyethyl)-rapamycin, Afinitor Disperz, CHEBI:68478, Rapamycin, 42-O-(2-hydroxyethyl)-, UNII-9HW64Q8G6G, RAD 001, 9HW64Q8G6G, RAD-001, NCGC00167512-01, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, Votubia, RAD, XIENCE V, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, Everolimus (RAD001), everolimusum, NSC733504, Everolimus (INN), Everolimus [USAN], Everolimus(RAD001), PubChem20048, Everolimus - RAD001, SCHEMBL4378, DSSTox_CID_20599, DSSTox_RID_79508, DSSTox_GSID_40599, Everolimus [USAN:INN:BAN], NVP-RAD-001, Everolimus, analytical standard, GTPL5889, RAD-001C, CHEMBL1908360, DTXSID0040599, HSDB 8255, Everolimus; RAD001; SDZ-RAD, HKVAMNSJSFKALM-GKUWKFKPSA-N, C53H83NO14, EX-A2057, Tox21_112510, BDBM50088378, AKOS015850977, ZINC169677008, CS-0064, DB01590, RL02051, AS-16971, AT-22180, HY-10218, LS-143292, CAS-159351-69-6, V2036, 351E696, Q-101413, BRD-K13514097-001-01-2, BRD-K13514097-001-05-3, dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone, Everolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited